Latest news
Context Therapeutics Inc (CNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:16:53 GMTContext Therapeutics Inc. Stock 12‑Month Price Target Cut to $4.56, Implies 557% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:13 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - BenzingaBenzinga · Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock TitanStock Titan · Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:44:29 GMTContext Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:14:11 GMTContext Therapeutics Inc. 1H 2026: Net income $(23.24)M, Diluted EPS $(0.24) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMTContext Therapeutics (NASDAQ: CNTX) reports $23.2 million loss and cash runway - Stock TitanStock Titan · Wed, 05 Aug 2026 20:10:38 GMT